Quantifying heterogeneity in a meta-analysis

Author(s): Higgins JP, Thompson SG

Abstract

The extent of heterogeneity in a meta-analysis partly determines the difficulty in drawing overall conclusions. This extent may be measured by estimating a between-study variance, but interpretation is then specific to a particular treatment effect metric. A test for the existence of heterogeneity exists, but depends on the number of studies in the meta-analysis. We develop measures of the impact of heterogeneity on a meta-analysis, from mathematical criteria, that are independent of the number of studies and the treatment effect metric. We derive and propose three suitable statistics: H is the square root of the chi2 heterogeneity statistic divided by its degrees of freedom; R is the ratio of the standard error of the underlying mean from a random effects meta-analysis to the standard error of a fixed effect meta-analytic estimate, and I2 is a transformation of (H) that describes the proportion of total variation in study estimates that is due to heterogeneity. We discuss interpretation, interval estimates and other properties of these measures and examine them in five example data sets showing different amounts of heterogeneity. We conclude that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity. One or both should be presented in published meta-analyses in preference to the test for heterogeneity.

Similar Articles

Incidence of endometrial hyperplasia

Author(s): Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, et al.

Seromucinous Tumors of the Ovary

Author(s): Kurman RJ, Shih IeM

Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia

Author(s): Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, et al.

Modifiable risk factors for cancer

Author(s): Stein CJ, Colditz GA

Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy

Author(s): Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, et al.

Risk factors for endometrial hyperplasia: results from a case-control study

Author(s): Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, et al.

High rate of endometrial hyperplasia in renal transplanted women

Author(s): Bobrowska K, Kamiński P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, et al.

Clinical parameters linked with malignancy in endometrial polyps

Author(s): Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, et al.

Measuring inconsistency in meta-analyses

Author(s): Higgins JP, Thompson SG, Deeks JJ, Altman DG

Bias in meta-analysis detected by a simple, graphical test

Author(s): Egger M, Davey Smith G, Schneider M, Minder C

Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women

Author(s): Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, et al.

Risk factors for adenomatous endometrial hyperplasia: a case-control study

Author(s): Kreiger N, Marrett LD, Clarke EA, Hilditch S, Woolever CA

Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy

Author(s): Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, et al.

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

Author(s): Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, et al.

Characteristics of women with a family history of ovarian cancer

Author(s): Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, et al.

Cigarette smoking, relative weight, and menopause

Author(s): Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, et al.

Tobacco smoking and cancer: a meta-analysis

Author(s): Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, et al.

Smoking and colorectal cancer: a meta-analysis

Author(s): Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, et al.

An aggregated analysis of hormonal factors and endometrial cancer risk by parity

Author(s): Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, et al.

IUD use and the risk of endometrial cancer

Author(s): Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N

Risk factors among young women with endometrial cancer: a Danish case-control study

Author(s): Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jønsson L, et al.

A case-control study of cancer of the endometrium

Author(s): Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, et al.

Epidemiology of endometrial cancer

Author(s): Elwood JM, Cole P, Rothman KJ, Kaplan SD

Family history and the risk of endometrial cancer

Author(s): Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E